Lantheus Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lantheus Holdings, Inc. on March 1, 2022. The filing reports a corporate governance event: the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on director compensation and appointment details rather than financial performance.
Material Changes
The material change reported is the appointment of Ms. Minnie Baylor-Henry to the Board of Directors on March 1, 2022. She was appointed as a Class II Director and designated as an independent director. She will serve on the Compensation Committee and the Science and Technology Committee.
Management Commentary and Compensation Details
Ms. Baylor-Henry is described as a renowned expert in regulatory affairs and compliance in the life sciences industry. Her compensation package includes:
- Cash Compensation: $55,000 annually for Board service, $7,500 for the Compensation Committee, and $5,000 for the Science and Technology Committee (prorated for partial years).
- Initial Equity Grant: Restricted Stock Units (RSUs) valued at $25,833.33, vesting in full on the first anniversary of the grant date.
- Annual Equity Grant: RSUs valued at $155,000.00 under the annual director equity program, vesting in full on the first anniversary of the grant date.
Ms. Baylor-Henry will also enter into a customary indemnification agreement with Lantheus and its wholly-owned subsidiary, Lantheus Medical Imaging, Inc.
Investor Verification Checklist
- Verify the independence status of Ms. Baylor-Henry under Nasdaq Stock Market rules.
- Confirm the total annual cash and equity compensation value for new directors.
- Review the specific vesting schedules for the initial and annual RSU grants.
- Check for any subsequent filings regarding changes to the Board composition or committee assignments.